12-Jun-2026
West Pharma raised to Overweight at Barclays on fundamentals
Seeking Alpha News (Tue, 9-Jun 11:28 AM ET)
West Appoints Michel Lagarde to be President and Chief Executive Officer
PRNewswire (Mon, 1-Jun 4:30 PM ET)
West to Participate in Upcoming Investor Conferences
PRNewswire (Tue, 28-Apr 6:00 AM ET)
West Pharmaceutical Services Raises Full-Year Guidance as High-Value Products Drive 21% Sales Growth
Market Chameleon (Thu, 23-Apr 7:45 AM ET)
West Pharmaceutical Raises 2026 Outlook as High-Value Products Drive Double-Digit Growth
Market Chameleon (Thu, 23-Apr 4:00 AM ET)
West Reports First-Quarter 2026 Results
PRNewswire (Thu, 23-Apr 6:00 AM ET)
West to Host First-Quarter 2026 Conference Call
PRNewswire (Thu, 9-Apr 6:00 AM ET)
PRNewswire (Tue, 31-Mar 11:47 AM ET)
West Pharmaceutical Lifts 2025 Outlook on Double-Digit HVP Component Growth and Strong Cash Flow
Market Chameleon (Thu, 23-Oct 4:26 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of June 12, 2026, WST stock price declined to $328.82 with 443,612 million shares trading.
WST has a beta of 1.27, meaning it tends to be more sensitive to market movements. WST has a correlation of 0.15 to the broad based SPY ETF.
WST has a market cap of $23.23 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $845 million in Revenue and $2.13 earnings per share. This beat revenue expectation by $66 million and exceeded earnings estimates by $.45.
In the last 3 years, WST traded as high as $415.73 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, IVV, VUG.
WST has outperformed the market in the last year with a price return of +46.6% while the SPY ETF gained +24.1%. WST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +42.4% and +1.9%, respectively, while the SPY returned +11.6% and -1.9%, respectively.
WST support price is $324.54 and resistance is $336.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.